HuGE Literature Finder
|
||
Records 1-6
|
APC:T1556fs and STK11 mutations in duodenal adenomas and adenocarcinomas.
Surgery today 2018 Mar . Kojima Yohei, Ohtsuka Kouki, Ohnishi Hiroaki, Abe Nobutsugu, Furuse Junji, Watanabe Takashi, Sugiyama Masano |
|
Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/?-catenin signaling pathway mutations.
Cancer 2016 Mar . Yuan Wei, Zhang Zhou, Dai Binghua, Wei Qing, Liu Jinjin, Liu Yuzhen, Liu Yun, He Lin, Zhou Daizh |
|
Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma.
PloS one 2016 11 (9): e0162929. Fu Tao, Sharmab Anup, Xie Fei, Liu Yanliang, Li Kai, Wan Weiwei, Baylin Stephen B, Wolfgang Christopher L, Ahuja Ni |
|
Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.
British journal of cancer 2015 Apr 112 (8): 1398-404. Matsubara A, Ogawa R, Suzuki H, Oda I, Taniguchi H, Kanai Y, Kushima R, Sekine |
|
Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
The Journal of pathology 2012 Dec . Matsubara A, Sekine S, Kushima R, Ogawa R, Taniguchi H, Tsuda H, Kanai Y |
|
KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma.
International journal of cancer. Journal international du cancer 2012 Oct . Fu T, Guzzetta AA, Jeschke J, Vatapalli R, Dave P, Hooker CM, Morgan R, Iacobuzio-Donahue CA, Liu B, Ahuja N |
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: